Courses



Two elective modules corresponding to a total of 15 ECTS-Credits must be passed:
Elective Modules (15 ECTS-Credits)
Go to the superordinate section
Elective Module 1: Patient-Oriented Aspects in Pharmacy (7.5 ECTS-Credits, 4 h) (no courses)
Prerequisites for registration: positive completion of compulsory modules 3 and 7
Learning Outcome: Students are able to describe the evidence-based drug therapy of specific diseases and the individualised / personalised drug therapy for specific patients and patient populations. They are able to optimise drug therapy, the medication management and can individually advise in consideration of communicative aspects. They understand the implementation and interpretation of specific diagnostic methods relevant to pharmacies.
Elective Module 2: Analysis of Natural Products (7.5 ECTS-Credits, 4 h) (no courses)
Prerequisites for registration: positive completion of compulsory module 2
Learning Outcome: The students demonstrate their practical knowledge of the application of modern methods in natural substance analysis for the detection of toxic / illegal substances in plant preparations. They are familiar with the basics of structure elucidation of complex compounds by MS and NMR and can describe the advantages of new analytical methods (e.g. HPLC-MS).
Elective Module 3: Cosmetics in Pharmacy (7.5 ECTS-Credits, 4 h ) (no courses)
Prerequisites for registration: successful completion of compulsory modules 5 and 6
Learning Outcome: The students have theoretical knowledge (historical, definitions as well as skin and skin appendages) and practical basic knowledge in the field of cosmetics, such as the independent production of selected products and their characterisation.
Elective Module 4: Drug Design (7.5 ECTS-Credits, 4 h) (no courses)
Prerequisites for registration: positive completion of compulsory module 4
Learning Outcome: Students are able to describe and apply modern methods for the discovery of new drugs using in silico and in vitro methods as well as current methods of planning and performing syntheses. As an example the analysis of structure-activity relationships with consideration of the 3D structure of the target or the lead optimisation in terms of pharmacokinetic and pharmacodynamic properties is mentioned.
Elective Module 5: Clinical Pharmacy (7.5 ECTS-Credits, 4 h) (no courses)
Prerequisites for registration: positive completion of compulsory modules 3 and 7
Learning Outcome: The students are familiar with medical-related workflows in hospital pharmacies and the importance of interdisciplinary consultation at the bedside. They are familiar with current opportunities for gene therapy and with gender-relevant aspects of drug therapy.
Elective Module 6: Complementary Medicine (7.5 ECTS-Credits, 4 h) (no courses)
Prerequisites for registration: positive completion of compulsory module 2
Learning Outcome: Students are able to explain the theoretical foundations of alternative treatment methods such as homeopathy and Traditional Chinese Medicine and to explain the materials and manufacturing instructions used. They have insights into the industrial production process of herbal medicines, the requirements for the quality of starting material and end product as well as their practical testing in the laboratory using chromatographic methods.
Elective Module 7: In-Depth Aspects of Pharmaceutical Technology (7.5 ECTS-Credits, 4 h) (no courses)
Prerequisites for registration: positive completion of compulsory module 5 and 6
Learning Outcome: The students gain insight into various pharmaceutical technological topics of industrial research and product development. They capture the theory and practical application of special dosage forms and selected medical devices.
Elective Module 8: Experimental Cancer Chemotherapy (7.5 ECTS-Credits, 4 h) (no courses)
Prerequisites for registration: positive completion of compulsory module 4
Learning Outcome: The students understand the mechanisms (e.g. relationship of structure and mutagenic / antitumour effect) of tumour development and treatment as well as the concept of a target-oriented drug design (drug targeting and prodrug concept) to minimize side effects. They are able to retrieve the relevant drug classes. They are familiar with preclinical methods of investigation, in vitro and in vivo methods for the evaluation of antitumour agents and the course (or replacement) of animal experiments.

Notes:
  • There may still be changes in the courses offered as well as room allocation and course dates.
  • The course descriptions found in the English version of the course catalogue are for informational purposes only. Authoritative information can be found in the "Vorlesungsverzeichnis" (German version of the course catalogue).